{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:49:27Z","timestamp":1753890567668,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012456","name":"National Social Science Fund of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012456","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To determine the interaction of electrical storm (ES) and impaired left ventircular ejection fraction (LVEF) on the mortality risk of patients with implantable cardioverter defibrillator (ICD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>A total of 554 Chinese ICD recipients from 2010 to 2014 were retrospectively included and the mean follow-up was 58 months. The proportions of dilated cardiomyopathy and the hypertrophic cardiomyopathy were 26.0% (144\/554) and 5.6% (31\/554), respectively. There were 8 cases with long QT syndrome, 6 with arrhythmogenic right ventricular cardiomyopathy and 2 with Brugada syndrome. Patients with prior MI accounted for 15.5% (86\/554) and pre-implantation syncope accounted for 23.3% (129\/554). A total of 199 (35.9%) patients had primary prevention indications for ICD therapy. Both ES and impaired LVEF (&amp;lt;40%) were independent predictors for all-cause mortality [hazard ratio (HR) 2.40, 95% CI 1.57\u20133.68, <jats:italic>P<\/jats:italic> &amp;lt; 0.001; HR 1.94, 95% CI 1.30\u20132.90, <jats:italic>P<\/jats:italic> = 0.001, respectively] and cardiovascular mortality (HR 4.63, 95% CI 2.68\u20137.98, <jats:italic>P<\/jats:italic> &amp;lt; 0.001; HR 2.56, 95% CI 1.47\u20134.44, <jats:italic>p<\/jats:italic> = 0.001, respectively). Compared with patients with preserved LVEF (\u226540%) and without ES, patients with impaired LVEF and ES had highest all-cause and cardiovascular mortality risks (HR 4.17, 95% CI 2.16\u20138.06, <jats:italic>P<\/jats:italic> &amp;lt; 0.001; HR 11.91, 95% CI 5.55\u201325.56, <jats:italic>P<\/jats:italic> &amp;lt; 0.001, respectively). In patients with impaired LVEF, ES increased the all-cause and cardiovascular mortality risks (HR 1.84, 95% CI 1.00\u20133.37, <jats:italic>P<\/jats:italic> = 0.034; HR 4.86, 95% CI 2.39\u20139.86, <jats:italic>P<\/jats:italic> &amp;lt; 0.001, respectively). In patients with ES, the deleterious effects of impaired LVEF seemed confined to cardiovascular mortality (HR 2.54, 95% CI 1.25\u20135.14, <jats:italic>p<\/jats:italic> = 0.038), and the HR for all-cause mortality was not significant statistically (HR 1.14, 95% CI 0.54\u20132.38, <jats:italic>P<\/jats:italic> = 0.735).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Both ES and impaired LVEF are independent predictors of mortality risk in this Chinese cohort of ICD recipients. The interaction of ES and impaired LVEF in patients significantly amplifies the deleterious effects of each other as distinct disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.937655","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T05:44:45Z","timestamp":1659073485000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Interaction between electrical storm and left ventricular ejection fraction as predictors of mortality in patients with implantable cardioverter defibrillator: A Chinese cohort study"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhengqin","family":"Zhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/europace\/eut304","article-title":"Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis","volume":"16","author":"Guerra","year":"2014","journal-title":"Europace."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cjca.2013.09.024","article-title":"Predictors of mortality in patients with an implantable cardiac defibrillator: a systematic review and meta-analysis","volume":"29","author":"Alba","year":"2013","journal-title":"Can J Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.jacc.2016.06.039","article-title":"Electrical storms in patients with implantable cardioverter-defibrillators for primary prevention","volume":"68","author":"Escande","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/europace\/euq428","article-title":"Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators","volume":"13","author":"Streitner","year":"2011","journal-title":"Europace."},{"key":"B5","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/eurheartj\/ehi726","article-title":"Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators","volume":"27","author":"Brigadeau","year":"2006","journal-title":"Eur Heart J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.amjcard.2005.08.058","article-title":"Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator","volume":"97","author":"Arya","year":"2006","journal-title":"Am J Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1161\/01.CIR.103.16.2066","article-title":"Electrical storm presages nonsudden death: the Antiarrhythmics versus implantable defibrillators trial","volume":"103","author":"Exner","year":"2001","journal-title":"Circulation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1093\/eurheartj\/ehl276","article-title":"Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial","volume":"27","author":"Hohnloser","year":"2006","journal-title":"Eur Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0735-1097(98)00495-1","article-title":"Electrical storm in patients with transvenous implantable cardioverter-defibrillators","volume":"32","author":"Credner","year":"1998","journal-title":"J Am Coll Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.eupc.2005.01.003","article-title":"Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy","volume":"7","author":"Gatzoulis","year":"2005","journal-title":"Europace."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.hrthm.2007.07.013","article-title":"Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy","volume":"4","author":"Sesselberg","year":"2007","journal-title":"Heart Rhythm."},{"key":"B12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.amjcard.2017.10.001","article-title":"Spectrum and outcome of patients who have undergone implantation of an implantable cardioverter defibrillator after aborted-sudden cardiac arrest","volume":"121","author":"Extramiana","year":"2018","journal-title":"Am J Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/europace\/eup091","article-title":"Implantable cardioverter defibrillators and their role in heart failure progression","volume":"11","author":"Cevik","year":"2009","journal-title":"Europace."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","article-title":"2016 ACC\/AHA\/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"68","author":"Yancy","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.jacc.2018.02.056","article-title":"Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator","volume":"71","author":"Chatzidou","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.hrthm.2015.07.034","article-title":"Electrical storm in patients with implantable cardioverter-defibrillator in the era of catheter ablation: implications for better rhythm control","volume":"12","author":"Nedios","year":"2015","journal-title":"Heart Rhythm."},{"key":"B19","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jacep.2017.06.006","article-title":"Efficacy of stellate ganglion blockade in managing electrical storm: a systematic review","volume":"3","author":"Meng","year":"2017","journal-title":"J Am Coll Cardiol EP."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.937655\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T05:44:48Z","timestamp":1659073488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.937655\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":19,"alternative-id":["10.3389\/fcvm.2022.937655"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.937655","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"article-number":"937655"}}